Remodeling of autologous saphenous vein grafts: The role of perivascular myofibroblasts

Circulation

Volumn 95, Issue 12, 1997, Pages 2684-2693

  Shi, Yi ^a   O'Brien Jr , James E ^b   Mannion, John D ^b   Morrison, Richard C ^b   Chung, Wooksung ^a   Fard, Ali ^a   Zalewski, Andrew ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Atherosclerosis; Bypass; Myofibroblast; Remodeling; Veins

Indexed keywords

ANIMAL TISSUE; ARTICLE; AUTOGRAFT; CELL DIFFERENTIATION; CELL MIGRATION; CORONARY ARTERY BYPASS GRAFT; CYTOSKELETON; HEART VENTRICLE REMODELING; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; SAPHENOUS VEIN; SMOOTH MUSCLE FIBER; SWINE; VEIN GRAFT;

EID: 0030997882     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.12.2684     Document Type: Article

References (37)

1. Spray TL, Roberts WC. Changes in saphenous veins used as aortocoronary bypass grafts. Am Heart J. 1977;94:500-516.
2. Vlodaver A, Edwards JE. Pathologic changes in aortic-coronary arterial saphenous vein grafts. Circulation. 1971;44:719-728.
3. Brody WR, Angell WW, Kosek JC. Histologic fate of the venous coronary artery bypass in dogs. Am J Pathol. 1972;66:111-130.
4. Unni KK, Kottke BA, Titus JL, Frye RL, Wallace RB, Brown AL. Pathologic changes in aortocoronary saphenous vein grafts. Am J Cordiol. 1974;34:526-532.
5. Haust MD, More RH, Movat HZ. The role of smooth muscle cells in the fibrogenesis of arteriosclerosis. Am J Pathol. 1960;37:377-389.
6. Ross R, Wight TN, Strandness E, Thiele B. Human atherosclerosis, I: cell constitution and characteristics of advanced lesions of the superficial femoral artery. Am J Pathol. 1984;114:79-93.
7. Gown AM, Tsukada T, Ross R. Human atherosclerosis, II: immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am J Pathol. 1986;125:191-207.
8. Shi Y, Pieniek M, Fard A, O'Brien J, Mannion JD, Zalewski A. Adventitial remodeling following coronary arterial injury. Circulation. 1996;93:340-348.
9. Shi Y, O'Brien JE Jr, Fard A, Mannion JD, Wang D, Zalewski A. Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation. 1996;94:1655-1664.
10. Holifield B, Helgason T, Jemelka S, Taylor A, Navran S, Allen J, Seidel C. Differentiated vascular myocytes: are they involved in neointimal formation? J Clin Invest. 1996;97:814-825.
11. Gabbiani G, Ryan GB, Majno G. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia. 1971;27:549-550.
12. Darby I, Skalli O, Gabbiani G. α-Smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest. 1990;63:21-29.
13. Welch MP, Odland GF, Clark RAF. Temporal relationships of F-actin bundle formation, collagen and fibronectin matrix assembly, and fibronectin receptor expression to wound contraction. J Cell Biol. 1990;110:133-145.
14. Kuhn C, McDonald JA. The roles of the myofibroblast in idiopathic pulmonary fibrosis. Am J Pathol. 1991;138:1257-1265.
15. Högemann B, Gillessen A, Böcker W, Rauterberg J, Domschke W. Myofibroblast-Iike cells produce mRNA for type I and III procollagens in chronic active hepatitis. Scand J Gastroenterol. 1993;28: 591-594.
16. Shi Y, O'Brien JE, Ala-Kokko L, Chung W, Mannion JD, Zalewski A. The origin of extracellular matrix synthesis during coronary repair. Circulation. 1997;95:997-1006.
17. Angelini GD, Bryan AJ, Williams HMJ, Morgan R, Newby AC. Distention promotes platelet and leukocyte adhesion and reduces short-term patency in pig arteriovenous bypass grafts. J Thorac Cardiovasc Surg. 1990;99:433-439.
18. McElroy DA. Connective tissue. In: Prophet EB, Mills B, Arrington JB, Sobin LH, eds. Laboratory Methods in Histotechnology. Washington, DC: American Registry of Pathology; 1992:132-135.
19. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W. Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: a report from the committee on vascular lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1995;92:1355-1374.
20. Desmoulière A, Geinoz A, Gabbiani F, Gabbiani G. Transforming growth factor-β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol. 1993;122:103-111.
21. Shi Y, O'Brien JE, Fard A, Zalewski A. Transforming growth factor-β1 expression and myofibroblast formation during arterial repair. Arterioscler Thromb Vasc Biol. 1996;16:1298-1305.
22. Schmitt-Gräff A, Desmoulière A, Gabbiani G. Heterogeneity of myofibroblast phenotypic features: an example of fibroblastic cell plasticity. Virchows Arch. 1994;425:3-24.
23. Skalli O, Bloom WS, Ropraz P, Azzarone B, Gabbiani G. Cytoskeletal remodeling of rat aortic smooth muscle cells in vitro: relationship to culture conditions and analogies to in vivo situations. J Submicrosc Cytol. 1986;18:481-493.
24. Kocher O, Gabbiani G. Cytoskeletal features of normal and atheromatous human arterial smooth muscle cells. Hum Pathol. 1986;17: 875-880.
25. Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis. 1986;6:131-138.
26. Ronnov-Jessen L, Petersen OW. Induction of α-smooth muscle actin by transforming growth factor-β1 in quiescent human breast gland fibroblasts: implications for myofibroblast generation in breast neoplasia. Lab Invest. 1993;68:696-707.
27. Vyalov S, Desmoulière A, Gabbiani G. GM-CSF-induced granulation tissue formation: relationship between macrophage and myofibroblast accumulation, Virchows Arch B Cell Pathol. 1993;63: 231-239.
28. Hofer H, Mihatsch MJ, Guggenheim R, Amsier B, Hasse J, Graedel E. Morphologic studies in saphenous vein grafts for aortocoronary bypass surgery, I: morphology of the graft using ordinary surgical preparation techniques, Thorac Cardiovasc Surg. 1981;29: 32-37.
29. Angelini GD, Breckenridge IM, Butchart EG, Armistead SH, Middleton KM, Henderson AH, Newby AC. Metabolic damage to human saphenous vein during preparation for coronary artery bypass grafting. Cardiovasc Res. 1985;19:326-334.
30. Schwartz SM, deBlois D, O'Brien ERM. The intima: soit for atherosclerosis and restenosis. Circ Res. 1995;77:445-465.
31. Camejo G, Lopez A, Lopez F, Quinones J. Interaction of low density lipoproteins with arterial proteoglycans; the role of charge and sialic acid content. Atherosclerosis. 1985;55:93-105.
32. Vijayagopal P, Srinivasan SR, Radhakrishnamurthy B, Berenson GS. Lipoprotein-proteoglycan complexes from atherosclerotic lesions promote cholesleryl ester accumulation in human monocytes/macrophages. Arterioscler Thromb. 1992;12:237-249.
33. Grondin CM, Campeau L, Lesperance J, Enjalbert M, Bourassa MG. Comparison of late changes in internal mammary artery and saphenous vein grafts in two consecutive series of patients 10 years after operation. Circulation. 1984;70(suppl I):I-1208-I-1212.
34. Lytle BW, Loop FD, Cosgrove DM, Ratliff NB, Easly K, Taylor PC. Long term (5 to 12 years) serial studies of internal mammary artery and saphenous vein coronary bypass grafts. J Thorac Cardiovasc Surg. 1985;89:248-258.
35. Nishioka T, Luo H, Berglund H, Eigler NL, Kim C-J, Tabak SW, Siegel RJ. Absence of focal compensatory enlargement or constriction in diseased human coronary saphenous vein grafts. Circulation. 1996;93:683-690.
36. Kriss JP, Revesz L. The distribution and fate of bromodeoxyuridine and bromodeoxycytidine in the mouse and rat. Cancer Res. 1962; 22:254-265.
37. Dean PN, Dolbeare F, Gratzner H, Rice GC, Gray JW. Cell-cycle analysis using a monoclonal antibody to BrdUrd. Cell Tissue Kinet. 1984;17:427-436.